doi: 10.1001/jama.2023.24539.
FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
- PMID: 37966831
- DOI: 10.1001/jama.2023.24539
Item in Clipboard
FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
JAMA.
.
No abstract available
Plain language summary
This Medical News article discusses the November 8 US Food and Drug Administration approval of the drug tirzepatide for chronic weight management in people with obesity or overweight with weight-related conditions.
Similar articles
-
Tirzepatide (Zepbound) for the Treatment of Obesity.Am Fam Physician. 2024 Aug;110(2):199-200. Am Fam Physician. 2024. PMID: 39172681 No abstract available.
-
Comparison table: some FDA-approved drugs for weight management.Med Lett Drugs Ther. 2018 Jun 4;60(1548):e98-e100. Med Lett Drugs Ther. 2018. PMID: 29913464 No abstract available.
-
FDA-Approved Drugs to Treat Overweight and Obesity.J Psychosoc Nurs Ment Health Serv. 2024 Aug;62(8):5-6. doi: 10.3928/02793695-20240621-79. Epub 2024 Aug 1. J Psychosoc Nurs Ment Health Serv. 2024. PMID: 39110903 No abstract available.
-
Are non-prescription medications needed for weight control?Obesity (Silver Spring). 2008 Mar;16(3):509-14. doi: 10.1038/oby.2007.100. Epub 2008 Jan 31. Obesity (Silver Spring). 2008. PMID: 18239604 Review.
-
Updates on obesity pharmacotherapy.Ann N Y Acad Sci. 2018 Jan;1411(1):106-119. doi: 10.1111/nyas.13542. Ann N Y Acad Sci. 2018. PMID: 29377198 Review.
Cited by
-
Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis.touchREV Endocrinol. 2024 Oct;20(2):72-80. doi: 10.17925/EE.2024.20.2.10. Epub 2024 Jun 6. touchREV Endocrinol. 2024. PMID: 39526060 Free PMC article.
-
Mechanisms by Which Pharmacotherapy May Impact Cancer Risk among Individuals with Overweight and Obesity.Cancers (Basel). 2024 Sep 26;16(19):3275. doi: 10.3390/cancers16193275. Cancers (Basel). 2024. PMID: 39409896 Free PMC article. Review.
-
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials.Int J Clin Pharm. 2024 Dec;46(6):1268-1280. doi: 10.1007/s11096-024-01779-x. Epub 2024 Jul 22. Int J Clin Pharm. 2024. PMID: 39037553 Free PMC article. Review.
-
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity.Drugs. 2024 Aug;84(8):933-952. doi: 10.1007/s40265-024-02029-0. Epub 2024 Jul 6. Drugs. 2024. PMID: 38970626 Free PMC article. Review.
-
The TOTAL trial for weight management participation: A randomized controlled trial protocol.Contemp Clin Trials. 2024 Sep;144:107611. doi: 10.1016/j.cct.2024.107611. Epub 2024 Jun 22. Contemp Clin Trials. 2024. PMID: 38914310
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
